HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous versus bilevel positive airway pressure in a patient with idiopathic central sleep apnea.

Abstract
A 57-yr-old man with idiopathic central apnea is reported. He presented at our hospital complaining of excessive daytime sleepiness. Polysomnography, including esophageal pressure monitoring, confirmed central sleep apnea with an apnea index of 27/h. He had mild non-insulin-dependent diabetes mellitus (NIDDM) but no signs of diabetic neuropathy or other background diseases. The ventilatory responses to hypoxia and hypercapnia tested while he was awake indicated increased respiratory chemosensitivity. We applied nasal continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BPAP) in an attempt to compare the possible difference in therapeutic efficacy. Although nasal CPAP completely reversed central apnea, nasal BPAP adversely affected both apnea length and frequency in an applied pressure-dependent manner. Arterial blood gas analyses while he was being treated indicted alveolar hypoventilation with CPAP and hyperventilation with BPAP. Additionally, administration of a mixed gas containing 5% CO2 through a face mask had a significant effect on the disappearance of central apnea in this patient. These findings support the theory that the arterial PCO2 level is critical in generating idiopathic central apnea and that nasal CPAP therapy may be effective in eliminating central apnea by raising the PaCO2.
AuthorsF Hommura, M Nishimura, M Oguri, H Makita, K Hosokawa, H Saito, K Miyamoto, Y Kawakami
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 155 Issue 4 Pg. 1482-5 (Apr 1997) ISSN: 1073-449X [Print] United States
PMID9105099 (Publication Type: Case Reports, Comparative Study, Journal Article)
Topics
  • Blood Gas Analysis
  • Humans
  • Male
  • Middle Aged
  • Polysomnography
  • Positive-Pressure Respiration (methods)
  • Sleep Apnea Syndromes (blood, diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: